Skip to main content

Austria expands EHR, adds vaccination e-record

Austria is planning a vaccination e-record as part of its response to the COVID-19 health crisis. A pilot programme is currently under development. The country is also expanding the scope of its ELGA EHR to incorporate greater physiological and medical imaging data integration.

Austrian health minister Rudolf Anschober discussed the scope and preparations under way for the pilot vaccination e-record at a meeting of the budgetary committee of the Austrian parliament.

According to Mr Anschober, outline planning for the new e-record has already been completed. The new e-record will build on the capabilities of Austria’s existing ELGA EHR system. Technical and organisational preparations should be complete by the beginning of June, Mr Anschober told MPs.

The states of Vienna, Styria, and Lower Austria have already committed to the pilot programme. Other states in the Austrian Federation have expressed interest in joining the pilot programme.

The new e-record will be used not only for any potential future COVID-19 vaccine. It will also be used for routine vaccinations, including HPV and annual influenza vaccines.

The Austrian Government is expanding the scope of the country’s EHR, the ELGA. A living will function is being added, similar to developments in Spain. The Government is also seeking greater integration with laboratory results and medical imaging data from third party providers.
Labels:
Location: London, UK

Comments

Post a Comment

Popular posts from this blog

Austria develops Smart Covid-19 Test

Austrian low power sensor firm ams AG has received funding from two Austrian Government ministries to develop a smart device to provide accurate testing for Covid-19. The hand held device is directly connected to a "medical data cloud", does not require a laboratory, and can deliver accurate test results within 15 minutes. The two Austrian Government departments funding the new device are the Federal Ministry of Climate Action, Environment, Energy, Mobility, Innovation and Technology (BMK), and the Federal Ministry for Digital and Economic Affairs (BMDW). ams has used the funds to develop a connected, smart version of a lateral flow test (LFT) device. Lateral flow tests are a standard approach for rapid point of care (PoC) testing. LFTs, which are usually analogue devices, are typically intuitive and easy to use, and are subject to strict regulatory requirements. A pregnancy strip test is a typical example of an analogue LFT device. The challenge for ams was threefold: to cre
Post a Comment
Read more

Heidelberg develops Unsupervised AI for motor disease

Researchers at the universities of Heidelberg in Germany, and Zurich in Switzerland have developed an AI model to detect human motor impairments and determine underlying diseases. The new software is also a test for how effective unsupervised AI behaviour analysis can be in discovering and determining complex disease states. Conventional supervised instrumented movement analysis is time-consuming, potentially subjective, and cost-intensive. It requires prior knowledge of behaviours of interest, and typically a large amount of video frame annotation. There is scope for human annotator bias, with different annotators focusing on different behaviours, while ignoring or minimising others. The researchers have developed uBAM ("unsupervised Behaviour Analysis and Magnification using Deep Learning"). This is a fully automatic, unsupervised diagnostic support system for behaviour analysis. The new system can extract and classify behaviour automatically, with the ability to compar
Post a Comment
Read more